discovered that in sporadic CCM, somatic mutations in the CCM1/2/3 genes account for only 19.4% of cases, with MAP3K3 mutations present in 37% of cases; notably, these two are mutually exclusive. The gene discussed is MAP3K3; the disease is cerebral cavernous malformation.